Literature DB >> 1878743

The diverse effects of cromakalim on tension and 86Rb efflux in canine arterial smooth muscle.

K Masuzawa1, T Matsuda, M Asano.   

Abstract

1. To characterize further the K+ channels opened by cromakalim in arterial smooth muscle, the effects of cromakalim on tension and 86Rb efflux were compared in endothelium-denuded strips of coronary, mesenteric and middle cerebral (MC) arteries of the dog. 2. Cromakalim relaxed strips precontracted with 20.9 mM K+. The maximum relaxation induced by cromakalim varied in the arteries used; 94% in the coronary artery, 60% in the mesenteric artery and only 38% in the MC artery. Cromakalim failed to relax arterial strips precontracted with 65.9 mM K+. 3. When the effects of cromakalim on 86Rb efflux were determined in 20.9 mM K(+)-contracted strips, cromakalim-induced relaxations were accompanied by a large increase in 86Rb efflux in the coronary artery, by a small increase in the mesenteric artery but by an apparent decrease in the MC artery. 4. When 10(-7) M nifedipine was added to 20.9 mM K(+)-contracted strips, to inactivate Ca2(+)-activated K+ (KCa) channels, cromakalim produced a greater increase (measured from the point at which cromakalim was administered) in 86Rb efflux than in the absence of nifedipine, suggesting that the effects of cromakalim on 86Rb efflux from the 20.9 mM K(+)-contracted strips may be the resultant of two opposing effects: an increased 86Rb efflux perhaps due to the opening of ATP-sensitive K+ (KATP) channels, and a decreased efflux due to the closing of KCa channels. 5. After the inactivation of Kca channels in 20.9mM K+-contracted strips, the cromakalim-induced increase in 86Rb efflux measured as area under the curve was eight times greater in the coronary artery than in the MC artery. The increase in 86Rb efflux in the mesenteric artery was intermediate between these extremes. 6. Cromakalim also increased the 86Rb efflux from 65.9 mm K+-contracted strips. This increase was not augmented by the addition of nifedipine. Under these conditions, a similar variation in efflux response (as area under the curve) for cromakalim was noted in the arteries used. 7. The relaxant responses of each artery to cromakalim were competitively antagonized by glibenclamide, a blocker of KATP channels. The cromakalim-induced increase in 86Rb efflux was also inhibited by glibenclamide. 8. These results suggest that cromakalim-opened K+ channels in the three arteries may differ in terms of their frequency of occurrence in the plasmalemma, their permeability to 86Rb and their ability to modulate tension development. On the other hand, the activities of Kca and voltage-sensitive K+ channels, estimated from the effects of nifedipine, were similar in the three arteries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878743      PMCID: PMC1908079          DOI: 10.1111/j.1476-5381.1991.tb12296.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.

Authors:  R J Winquist; L A Heaney; A A Wallace; E P Baskin; R B Stein; M L Garcia; G J Kaczorowski
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

2.  Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue.

Authors:  U Quast; Y Baumlin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

3.  Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein.

Authors:  U Quast
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

4.  In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.

Authors:  U Quast; N S Cook
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

5.  Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.

Authors:  C Wilson
Journal:  J Auton Pharmacol       Date:  1989-02

6.  Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.

Authors:  I Cavero; S Mondot; M Mestre
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

7.  Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.

Authors:  R E Buckingham; T C Hamilton; D R Howlett; S Mootoo; C Wilson
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

8.  Evidence for reduced beta-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats.

Authors:  M Asano; K Masuzawa; T Matsuda
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

9.  Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.

Authors:  N S Cook; U Quast; R P Hof; Y Baumlin; C Pally
Journal:  J Cardiovasc Pharmacol       Date:  1988-01       Impact factor: 3.105

10.  Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.

Authors:  N S Cook; S W Weir; M C Danzeisen
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

View more
  2 in total

1.  The relaxant effects of cromakalim (BRL 34915) on human isolated airway smooth muscle.

Authors:  J Cortijo; B Sarriá; C Pedrós; M Perpiñá; F Paris; E Morcillo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

2.  Charybdotoxin-sensitive K+ channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats.

Authors:  M Asano; K Masuzawa-Ito; T Matsuda
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.